[13C6]-Mirabegron

[13C6]-Mirabegron is a stable isotope-labeled form of Mirabegron, which is a beta-3 adrenergic receptor agonist used in the treatment of overactive bladder syndrome. As a stable isotope-labeled compound, [13C6]-Mirabegron is used in various research studies and clinical trials to investigate the pharmacokinetics and metabolism of Mirabegron. The chemical formula of [13C6]-Mirabegron is C21H24N4O2, and its molecular weight is 372.44 g/mol. The compound contains six carbon-13 atoms, which can be detected and quantified using various analytical techniques such as mass spectrometry. In terms of usage, [13C6]-Mirabegron is typically administered orally as a tablet or capsule, and its pharmacokinetics can be studied by analyzing its presence and concentration in blood, urine, and other biological samples. The stable isotope-labeled compound can also be used to evaluate drug-drug interactions and assess the effects of different dosing regimens on Mirabegron metabolism. Overall, [13C6]-Mirabegron is a valuable tool in drug development and research, allowing for precise and accurate evaluation of Mirabegron's pharmacokinetics and metabolism. Its usage can lead to a better understanding of the drug's safety, efficacy, and optimal dosing regimens in patients with overactive bladder syndrome.